text: Retention on lifelong antiretroviral therapy (ART), yo
  It's crucial to keep it going, you know
  Preventin' HIV drug resistance, that's the aim
  Especially in resource-limited settings, we gotta maintain
  
  In this era of patients on ART risin' high
  Masterin' their care, it's a strategic try
  Programmatic interventions need to be strong
  To keep 'em on track, so they don't go wrong
  
  But in Cameroon, there's some lapses and uncertainty
  With the WHO sampling approach, it's not clear to see
  So our aim is to find out the national performance, yeah
  And what determines retention at 12 months, we're here to share